Biobanking as a Newsletter – Nov 2022
Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. We hope you will find this enriching and valuable. Please do let us know …
Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. We hope you will find this enriching and valuable. Please do let us know …
After three years gap, we conducted two successful ‘OpenSpecimen Annual Community Meet‘ (OSCON22) in St. Louis (USA) on Sept 19-20th and on Oct 18th in Perth (Australia). The goal of …
Molecular biologist Attili has been a lead researcher and developer of organoids, which are tiny, self-organized three-dimensional tissue cultures derived from stem cells. Organoids have fundamentally opened up a brand …
There are six national centers (6NCs) for advanced and specialized medicine in Japan that conduct basic and clinical research on major diseases that substantially impact national health. Disease-specific bioresources and …
Qatar Biobank, a member of Qatar Foundation (QF), has made significant progress over the past 10 years, with an increase in a number of participants and studies. The flagship Cohort …
MyAfroDNA is a limited liability company that provides a solution to the significant lack of African representation in translational and genomics research. The African-centric biobank offers access to ethically sourced …
The Million Veteran Program (MVP), which is run by Veterans Affairs and holds data on over 150,000 Black Americans. Established in 2011, the MVP has enrolled 903,000 contributors and is …
Tampa General Hospital and the University of South Florida (USF) Health Morsani College of Medicine are partnering to establish a medical research biorepository. The Health Precision Medicine Biorepository intends to …
Prof. Juergen Scheele, Chief Medical Officer, Innoplexus highlights that healthcare professionals must come together to ensure that licensing of biospecimens for cancer research follows the highest ethical standards and is …
Van Andel Institute’s Biorepository is the recipient of a five-year, $7.9 million contract from the National Cancer Institute (NCI), part of the National Institutes of Health, to continue serving as …